Novartis, MSH, and Other Partners Discuss Novartis Access, #AccessHealth in Basel

Novartis, MSH, and Other Partners Discuss Novartis Access, #AccessHealth in Basel

MSH's Douglas Keene, PharmD, MHS, Vice President, Pharmaceuticals & Health Technologies Group, was among the speakers at a recent event in Basel, Switzerland, hosted by Novartis, with representatives from NGOs, academia, and government discussing how to expand access to health in developing countries, including through the newly-launched program, Novartis Access.

MSH is partnering on Novartis Access to help empower governments of low- and lower-middle-income countries to provide access to health for chronic diseases patients who need it most. Ensuring affordable and equitable access to medicines is critical to achieving health for all -- and central to MSH's mission and health-systems strengthening approach.

But, what does access to medicine really mean, especially when it comes to managing noncommunicable diseases (NCDs) in developing countries? Keene and other panelists discussed:

“Novartis is leading the way in helping to address a problem we’re all grappling with,” said Keene.

Novartis Access was launched earlier this year in Kenya. Novartis is headquartered in Basel.

Learn more about how Novartis Access will work and what makes it novel:

Follow the latest about Novartis Access on Twitter using hashtag #AccessHealth.


More about Novartis Access